Atropine Sulfate

Atropine sulfate

Country of origin: Russia, Voronezhkhimpharm Russia, Dalkhimfarm Russia, Moscow Endocrine Plant Russia, Kharkov State Scientific Center for Clinical Laboratory Medicine Ukraine, Ergofarm Russia

Pharm-Group: M-anticholinergics

Manufacturers: Veropharm/Voronezh branch (Russia), Voronezhkhimpharm (Russia), Dalkhimfarm (Russia), Moscow Endocrine Plant (Russia), Kharkov State Research Center for Clinical Laboratory Medicine (Ukraine), Ergofarm (Russia)

International name: Atropine

Synonyms: Atromed, Atropine, Atropine sulfate, Atropine ointment

Dosage forms: solution for injection 0.1%, eye drops 1%, solution for injection 0.05%

Composition: Active ingredient - atropine.

Indications for use: Peptic ulcer of the stomach and duodenum, pylorospasm, cholelithiasis, spasms of the intestines and urinary tract, bradyarrhythmias, for preoperative sedation, poisoning with phosphorus poisoning, during X-ray studies of the gastrointestinal tract, bronchial asthma, bronchitis with hyperproduction of mucus, fundus examination, for creating functional rest in inflammatory diseases and eye injuries.

Contraindications: Glaucoma, ulcerative colitis, hiatal hernia, obstructive bowel and urinary tract diseases, paralytic ileus, toxic megacolon.

Side effects: Headache, dizziness, loss of touch, xerostomia, mydriasis, paralysis of accommodation, tachycardia, intestinal and bladder atony.

Interaction: Weakens the effect of m-cholinomimetics and anticholinesterase drugs.

Overdose: No data available.

Special instructions: No data available.

Literature: Encyclopedia of Medicines 2004, Encyclopedia of Medicines 2004.